Scholarlink

Objectives <p>To clarify the combined contribution of positron emission tomography-computed tomography (PET-CT) and video-assisted thoracoscopic surgery (VATS) pleural biopsy to diagnostic accuracy, perioperative outcomes, and long-term prognosis in patients with unexplained pleural effusion.</p> Methods <p>We retrospectively reviewed 29 consecutive patients who underwent both PET-CT and VATS biopsy for unexplained pleural effusion between 2009 and 2024. Imaging findings and pathological diagnosis, operative variables, complications, and overall survival were analyzed.</p> Results <p>Among 13 PET-negative patients, 4 (30.8%) had malignancy on VATS biopsy. Among 16 PET-positive patients, 5 (31.3%) had benign pathology. PET-CT findings were not associated with operative time, blood loss, or duration of chest tube. Postoperative complications occurred in 4 patients (13.8%), with no difference between PET-positive and negative groups. Complications included prolonged air leak, difficult-to-control pain, and thromboembolic events. Survival was significantly worse in malignant than benign cases (5-year overall survival: 29% vs. 56%, <i>p</i> = 0.02). When patients were grouped into four combined PET-CT/VATS biopsy categories, survival did not significantly differ among the groups (<i>p</i> = 0.11).</p> Conclusion <p>PET-CT and VATS biopsy were not always concordant, reinforcing the role of VATS biopsy for definitive diagnosis even when PET-CT is negative. Prognosis was more associated with VATS biopsy pathology than with PET-CT. Perioperative complications after VATS biopsy were not uncommon, particularly in patients with multiple comorbidities.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Combined PET-CT and VATS biopsy in pleural effusion: diagnostic accuracy, surgical factors, and prognosis—a retrospective study

  • 期刊论文

  • 发表日期：

    2026年7月3日

查看全文
  • Kiyoki Okamoto,
  • Kenji Kimura,
  • Toru Kimura,
  • Hideki Nagata,
  • Eriko Fukui,
  • Takashi Kanou,
  • Naoko Ose,
  • Yasushi Shintani

摘要

Objectives

To clarify the combined contribution of positron emission tomography-computed tomography (PET-CT) and video-assisted thoracoscopic surgery (VATS) pleural biopsy to diagnostic accuracy, perioperative outcomes, and long-term prognosis in patients with unexplained pleural effusion.

Methods

We retrospectively reviewed 29 consecutive patients who underwent both PET-CT and VATS biopsy for unexplained pleural effusion between 2009 and 2024. Imaging findings and pathological diagnosis, operative variables, complications, and overall survival were analyzed.

Results

Among 13 PET-negative patients, 4 (30.8%) had malignancy on VATS biopsy. Among 16 PET-positive patients, 5 (31.3%) had benign pathology. PET-CT findings were not associated with operative time, blood loss, or duration of chest tube. Postoperative complications occurred in 4 patients (13.8%), with no difference between PET-positive and negative groups. Complications included prolonged air leak, difficult-to-control pain, and thromboembolic events. Survival was significantly worse in malignant than benign cases (5-year overall survival: 29% vs. 56%, p = 0.02). When patients were grouped into four combined PET-CT/VATS biopsy categories, survival did not significantly differ among the groups (p = 0.11).

Conclusion

PET-CT and VATS biopsy were not always concordant, reinforcing the role of VATS biopsy for definitive diagnosis even when PET-CT is negative. Prognosis was more associated with VATS biopsy pathology than with PET-CT. Perioperative complications after VATS biopsy were not uncommon, particularly in patients with multiple comorbidities.